Definium Therapeutics, Inc. (DFTX) stock
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$32.08−0.92 (-2.79%)
Close on Nov 13, 2026Market cap $4.31BP/E –Yield –
Definium Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Definium Therapeutics's price to book ratio was 5.0× on Nov 11, 2026, against 7.4× a year earlier. Over the last 5 years it ranged from 0.5× to 17.6×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.0× | −2.8 |
| 2025 | Dec 31, 2025 | 7.9× | +5.7 |
| 2024 | Dec 31, 2024 | 2.2× | +0.6 |
| 2023 | Dec 29, 2023 | 1.5× | +1.0 |
| 2022 | Dec 30, 2022 | 0.5× | −4.3 |
| 2021 | Dec 31, 2021 | 4.8× | – |
See a number that looks wrong?